3.4426
Universe Pharmaceuticals Inc stock is traded at $3.4426, with a volume of 812.
It is down -1.64% in the last 24 hours and down -34.43% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$3.50
Open:
$3.34
24h Volume:
812
Relative Volume:
0.00
Market Cap:
$1.90M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-2.0251
EPS:
-1.7
Net Cash Flow:
$1.08M
1W Performance:
-5.68%
1M Performance:
-34.43%
6M Performance:
-38.30%
1Y Performance:
-95.19%
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
UPC
Universe Pharmaceuticals Inc
|
3.3643 | 1.97M | 32.31M | -6.16M | 1.08M | -1.70 |
|
ZTS
Zoetis Inc
|
118.05 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.27 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.9025 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.14 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.73 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Universe Pharmaceuticals Inc Stock (UPC) Latest News
Why Universe Pharmaceuticals INC stock is seen as undervalued2025 Year in Review & Verified Chart Pattern Signals - newser.com
Why Collegium Pharmaceutical Inc. stock is popular among millennialsPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Pininfarina S.p.A. (PNF) stock expanding market penetration2025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Is Universe Pharmaceuticals INC stock trading near support levelsJuly 2025 Outlook & AI Based Buy/Sell Signal Reports - newser.com
Universe Pharmaceuticals Inc (UPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How supply chain issues affect Universe Pharmaceuticals INC stockProduct Launch & Low Risk Investment Opportunities - newser.com
What institutional flow reveals about Universe Pharmaceuticals INCProduct Launch & Safe Entry Point Alerts - newser.com
What is the fair value of Universe Pharmaceuticals INC stock nowJuly 2025 Market Mood & Long-Term Safe Investment Ideas - newser.com
Is Universe Pharmaceuticals INC building a consolidation baseWeekly Trend Recap & Real-Time Volume Spike Alerts - newser.com
Price action breakdown for Universe Pharmaceuticals INCWeekly Trend Summary & Safe Capital Growth Plans - newser.com
Does Universe Pharmaceuticals INC fit your quant trading model2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
What data driven models say about Universe Pharmaceuticals INC’s future2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Is Universe Pharmaceuticals INC stock a contrarian buyDividend Hike & Consistent Profit Trading Strategies - newser.com
Visualizing Universe Pharmaceuticals INC stock with heatmaps2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Will Universe Pharmaceuticals INC stock split attract more investorsBull Run & Free Accurate Trade Setup Notifications - Fundação Cultural do Pará
Afrimex: Sustainability And Transformation In Ghana’s Gold Mining Industry - Universe News Network
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):